1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SYNTHETIC BIOLOGY HEALTHCARE APPLICATIONS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Enzymes
5.3. Synthetic DNA & RNA
5.4. Chassis Organisms
5.5. Xeno-nucleic Acids (XNA)
5.6. Others
6. SYNTHETIC BIOLOGY HEALTHCARE APPLICATIONS MARKET BY APPLICATION
6.1. Introduction
6.2. Drug Discovery & Development
6.3. Diagnostics
6.4. Vaccine Development
6.5. Regenerative Medicine
6.6. Gene & Cell Therapy
6.7. Others
7. SYNTHETIC BIOLOGY HEALTHCARE APPLICATIONS MARKET BY END USER
7.1. Introduction
7.2. Pharmaceutical & Biotechnology Companies
7.3. Academic & Research Institutes
7.4. Contract Research Organizations (CROs)
7.5. Hospitals & Clinics
7.6. Others
8. SYNTHETIC BIOLOGY HEALTHCARE APPLICATIONS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Ginkgo Bioworks
10.2. GenScript Biotech
10.3. Thermo Fisher Scientific
10.4. Illumina
10.5. Danaher Corporation
10.6. AbCellera Biologics
10.7. Precigen
10.8. Poseida Therapeutics
10.9. Mammoth Biosciences
10.10. Codexis
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations